Special purpose acquisition company, Deep Medicine Acquisition (DMAQ), has terminated a business combination agreement with Chinese automaker Chijet Motor Company after due diligence.
The agreement was announced in July, as part of which the combined company carried an implied enterprise value of about $2.55B.
The amendments to the agreement during the period of due diligence included a revised valuation.
No other reasons were specified by the healthcare-focused SPAC for the termination of the business combination.